Position in LGND
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$7,091,478
+$2,926,780 QoQ
Shares Held
22,435
+7.6% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#91
of 413 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $119,502,354 across 21 Biotechnology names. LGND ranks #4 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75,388 | $37,447,481 | |
| 2 | RPRX |
Royalty Pharma plc
|
573,521 | $32,157,322 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,578 | $7,219,346 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
This page
|
22,435 | $7,091,478 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
121,755 | $6,916,901 | |
| 6 | CYTK |
Cytokinetics Inc
|
51,443 | $4,382,428 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
19,711 | $3,691,476 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
14,699 | $3,597,874 |
All Filings in LGND
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,091,478 | 22,435 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,164,698 | 20,860 | Shares | Other | 2026-05-04 | |
| 2025-12-31 | $3,978,978 | 21,045 | Shares | Other | 2026-01-29 | |
| 2025-09-30 | $3,672,643 | 20,733 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,388,146 | 12,211 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,095,859 | 19,934 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,544,565 | 14,415 | Shares | Other | 2025-01-24 | |
| 2024-09-30 | $1,447,700 | 14,464 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $913,967 | 10,847 | Shares | Other | 2024-07-25 | |
| 2024-03-31 | $660,457 | 9,035 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $327,532 | 4,586 | Shares | Other | 2024-01-31 | |
| 2023-06-30 | $909,829 | 12,619 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,743,076 | 23,696 | Shares | Other | 2023-05-04 | |
| 2022-12-31 | $1,063,589 | 15,922 | Shares | Other | 2023-01-26 | |
| No filing history on record for this holder in this stock. | ||||||